| Factors associated with pharmacists’ perceptions of their working conditions and safety and effectiveness of patient care NW Tsao, LD Lynd, L Gastonguay, K Li, B Nakagawa, CA Marra Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (1), 18-27, 2016 | 49 | 2016 |
| Exponential smoothing method for forecasting drug expenditures MM D’Sa, RS Nakagawa, DS Hill, JK Tan American Journal of Health-System Pharmacy 51 (20), 2581-2588, 1994 | 13 | 1994 |
| Pharmacists’ perceptions of their working conditions and the factors influencing this: results from 5 Canadian provinces NW Tsao, S Salmasi, K Li, B Nakagawa, LD Lynd, CA Marra Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 153 (3), 161-169, 2020 | 12 | 2020 |
| Applying research to the policy cycle: implementing and evaluating evidence-based drug policies in British Columbia M Maclure, RS Nakagawa, BC Carleton JAPANESE PHARMACOLOGY AND THERAPEUTICS 31 (8), 697-717, 2003 | 11 | 2003 |
| Drug-related problems identified and resolved using pharmaceutical care versus traditional clinical monitoring S Shalansky, R Nakagawa, A Wee Canadian Journal of Hospital Pharmacy 49 (6), 1996 | 11 | 1996 |
| Theophylline-furosemide interaction? RS Nakagawa, PF Conlon, CE Johnson American Journal of Hospital Pharmacy 39 (2), 242-249, 1982 | 7 | 1982 |
| Regulation and innovation in practice–Not a “drug interaction”? RT Tsuyuki, RS Nakagawa Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 152 (3), 143-144, 2019 | 6 | 2019 |
| Reference-based pricing B Nakagawa, R Hudson CMAJ 162 (1), 12-12-b, 2000 | 6 | 2000 |
| Calculator programs to deal with non-steady state, multiple dosage regimen clinical pharmacokinetics RJ Ensom, RS Nakagawa International journal of bio-medical computing 14 (4), 287-309, 1983 | 6 | 1983 |
| Obtaining a critical care pharmacist position: a marketing case study TP Stratton, B Wu, RS Nakagawa Canadian Journal of Hospital Pharmacy 46 (3), 1993 | 4 | 1993 |
| The effect of pharmacy intervention on aminoglycoside costs. RT Tsuyuki, RS Nakagawa The Canadian Journal of Hospital Pharmacy 40 (2), 51-56, 1987 | 4 | 1987 |
| Expensive drugs for rare diseases in Canada: what value and at what cost? S Sirrs, H Anderson, B Jiwani, LD Lynd, E Lun, B Nakagawa, D Regier, ... Healthcarepapers 21 (1), 10-26, 2023 | 3 | 2023 |
| An evaluation of bylaw and policy changes on pharmacy robberies in British Columbia M Andresen, E Mann, T Hodgkinson, S Thacker, B Nakagawa Crime Science 8 (1), 2019 | 3 | 2019 |
| More the same than different: Worldwide drug policy issues B Nakagawa The Journal of Ambulatory Care Management 27 (3), 194-201, 2004 | 3 | 2004 |
| The development of a drug measurement service at St. Paul's Hospital: a pharmacy perspective. RJ Ensom, CC Godwin, RS Nakagawa The Canadian Journal of Hospital Pharmacy 35 (5), 135-142, 1982 | 3 | 1982 |
| Carleton. 2001.“ M Maclure, RS Nakagawa, C Bruce Applying Research to the Policy Cycle: Implementing and Evaluating Evidence …, 0 | 2 | |
| Expensive Drugs for Rare Diseases in Canada: Time for Action Everywhere and by Everyone. S Sirrs, H Anderson, B Jiwani, E Lun, B Nakagawa, D Regier, S Rizzardo, ... Healthcarepapers 21 (1), 74-80, 2023 | 1 | 2023 |
| Prescription Drug Systems and Price Control in Canada RS Nakagawa JL & Pol'y 15, 1103, 2007 | 1 | 2007 |
| Reference-based pricing M McGregor CMAJ 162 (1), 14-14, 2000 | 1 | 2000 |
| An automatic substitution policy for cefazolin. RS Nakagawa The Canadian Journal of Hospital Pharmacy 39 (4), 105-106, 1986 | 1 | 1986 |
Larry LyndProfessor, Epidemiology, University of British Columbia在 ubc.ca 的电子邮件经过验证
